Spencer, JA and Perren, TJ orcid.org/0000-0001-8472-8856 (2010) Recent EORTC and MRC UK studies: implications for imaging ovarian cancer. Cancer Imaging, 10 (1). pp. 135-136. ISSN 1740-5025
Abstract
For many years the primary management of newly diagnosed advanced ovarian cancer has been cytoreductive surgery followed by chemotherapy, and the mainstay of follow-up of treated women has been serial assay of serum CA-125. The findings of 2 recent research protocols have a significant effect on these aspects of management.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2010 International Cancer Imaging Society |
Keywords: | Biomarkers, Tumor; CA-125 Antigen; Diagnostic Imaging; Female; Humans; Neoplasm Recurrence, Local; Neoplasm, Residual; Ovarian Neoplasms; Radiography; Randomized Controlled Trials as Topic; United Kingdom |
Dates: |
|
Institution: | The University of Leeds |
Depositing User: | Symplectic Publications |
Date Deposited: | 18 Oct 2017 14:40 |
Last Modified: | 18 Oct 2017 14:48 |
Status: | Published |
Publisher: | Biomed Central |
Identification Number: | 10.1102/1470-7330.2010.0018 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:100573 |
Download not available
A full text copy of this item is not currently available from White Rose Research Online